increased T cell derived lymphoma incidence_Epm2a<Tg(TcraK,TcrbK)TG-BFlv>/Epm2a<+>

http://metadb.riken.jp/0002024IC57BL6C57BL10C57BRcdCBAJEpm2aTgTcraKTcrbKTGBFlvEpm2aEpm2aEpm2aTgTcraKTcrbKTGBFlv

increased T cell derived lymphoma incidence_Epm2a<Tg(TcraK,TcrbK)TG-BFlv>/Epm2a<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• epilepsy, progressive myoclonic epilepsy, type 2 gene alpha
  http://metadb.riken.jp/db/mgi_rdf/MGI:1341085

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Epm2a<Tg(TcraK,TcrbK)TG-BFlv>/Epm2a<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Epm2a<+>|Epm2a<Tg(TcraK,TcrbK)TG-BFlv>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * C57BL/10 * C57BR/cd * CBA/J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased T cell derived lymphoma incidence
  http://purl.obolibrary.org/obo/MP_0002024

文献

http://purl.org/net/cito/citesAsAuthority

• Yin. Wang, et.al., Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling., Cancer cell, 2006, 10
  http://rdf.ncbi.nlm.nih.gov/pubmed/16959610